HYBRID EVENT: You can participate in person at Rome, Italy from your home or work.
Ketogenic dietary therapies (KDT) represent a collection of high-fat, adequate-protein, and low-carbohydrate diets meticulously designed to shift the body's primary energy source from glucose to ketones. Originating as a treatment for epilepsy in the 1920s, the therapeutic use of ketogenic diets has expanded, showing promise in managing other neurological disorders, certain metabolic conditions, and as a potential adjunct in cancer therapy. The classical ketogenic diet is characterized by a ratio of 4:1 or 3:1 of fats to combined proteins and carbohydrates, meticulously calculated to induce and maintain ketosis, a metabolic state where the body burns fat for energy more efficiently.
By significantly reducing carbohydrate intake, the body is forced to turn to fat as its primary energy source, resulting in the production of ketone bodies in the liver. These ketones then serve as an alternative energy source for the brain and other tissues. The diet requires strict adherence and careful monitoring by healthcare professionals to ensure nutritional adequacy and to manage potential side effects, such as gastrointestinal disturbances, nutrient deficiencies, and altered lipid profiles.
Beyond its original application for epilepsy, research into ketogenic dietary therapies has expanded their potential benefits to include weight management, improved insulin sensitivity, and a possible reduction in inflammation. However, while promising, the long-term effects and applicability of KDT for broader populations remain areas of ongoing research. As with any significant dietary adjustment, individuals should consult healthcare professionals before embarking on a ketogenic diet to ensure it aligns with their health needs and goals.
